Assembly Biosciences, Inc. (ASMB): Price and Financial Metrics
ASMB Price/Volume Stats
| Current price | $10.62 | 52-week high | $19.93 |
| Prev. close | $10.90 | 52-week low | $10.27 |
| Day low | $10.61 | Volume | 12,000 |
| Day high | $11.06 | Avg. volume | 26,898 |
| 50-day MA | $12.58 | Dividend yield | N/A |
| 200-day MA | $14.88 | Market Cap | 79.68M |
ASMB Stock Price Chart Interactive Chart >
Assembly Biosciences, Inc. (ASMB) Company Bio
Assembly Biosciences develops oral therapies for intractable infectious diseases in the United States. The company focuses on the hepatitis B virus and C. difficile-associated infections. The company was founded in 2005 and is based in New York, New York.
ASMB Price Returns
| 1-mo | -18.12% |
| 3-mo | -29.95% |
| 6-mo | -29.85% |
| 1-year | N/A |
| 3-year | -57.45% |
| 5-year | -94.21% |
| YTD | -32.70% |
| 2024 | 60.35% |
| 2023 | -36.92% |
| 2022 | -44.21% |
| 2021 | -61.49% |
| 2020 | -70.43% |
Continue Researching ASMB
Want to see what other sources are saying about Assembly Biosciences Inc's financials and stock price? Try the links below:Assembly Biosciences Inc (ASMB) Stock Price | Nasdaq
Assembly Biosciences Inc (ASMB) Stock Quote, History and News - Yahoo Finance
Assembly Biosciences Inc (ASMB) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...